Application of Co-Amorphous Technology for Improving the Physicochemical Properties of Amorphous Formulations

Mol Pharm. 2019 May 6;16(5):2142-2152. doi: 10.1021/acs.molpharmaceut.9b00105. Epub 2019 Apr 18.

Abstract

Co-amorphous technology was recently introduced to stabilize drugs in the amorphous state for drug development. We examined the predictability of the formation of co-amorphous systems and identified two reliable indicators of successful formation: (1) a negative Δ Hmix value and (2) small Δlog P between components. Moreover, we found that the stability of co-amorphous systems was improved when (1) Δ Hmix was negative and (2) amorphous forms of the constituent compounds were stable. Furthermore, we concluded that co-amorphous systems with small (negatively large) Δ Hmix values had lower hygroscopicity. Typically, amorphous solid dispersions exhibit hygroscopicity because polymers exhibit large hygroscopicity. We proved the superiority of co-amorphous technology over amorphous solid dispersion in this respect. Our results provide methods for (1) establishing a screening method and (2) improving hygroscopicity, which may make co-amorphous technology more useful than amorphous solid dispersion technology.

Keywords: co-amorphous; hydrogen bonds; hygroscopicity; lipophilicity; mixing enthalpy; physical stability; screening.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Crystallization
  • Drug Compounding / methods*
  • Drug Design*
  • Drug Discovery / methods*
  • Drug Stability*
  • Drug Storage
  • Felodipine / chemistry
  • Hydrogen Bonding
  • Indomethacin / chemistry
  • Polymers / chemistry
  • Solubility
  • Spectroscopy, Near-Infrared
  • Wettability

Substances

  • Polymers
  • Felodipine
  • Indomethacin